Mineralocorticoid receptors and glucocorticoid receptors

Clinical Endocrinology

Volumn 45, Issue 6, 1996, Pages 651-656

  Funder, John W ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR;

HORMONE RESISTANCE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0030453496     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.8540862.x     Document Type: Review

References (43)

1. Agarwal, A.K., Monder, C., Eckstein, B. & White, P.C. (1989) Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. Journal of Biological Chemistry, 264, 18939-18943
2. Albiston, A., Obeyesekere, V., Smith, R. & Krozowski, Z.S. (1994) Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type II enzyme. Molecular and Cellular Endocrinology, 105, R11-R17.
3. Arai, K., Tsigos, C., Suzuki, Y., Irony, I., Karl, M., Listwak, S. & Chrousos, G.P. (1994) Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy. Journal of Clinical Endocrinology and Metabolism, 79, 1019-1023.
4. Armanini, D., Kuhnle, U., Strasser, T., Dorr, H., Weber, P.C., Stockigt, J.R., Pearce, P. & Funder, J.W. (1985) Aldosterone-receptor deficiency in pseudohypoaldosteronism. New England Journal of Medicine, 313, 1178-1181.
5. Arriza, J.L., Weinberger, C. Cerelli, G., Glaser, T.M., Handelin, B.L., Housman, D.E. & Evans, R.M. (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptors. Science, 237, 268-275.
6. Bamberger, C.M., Schulte, H.M. & Chrousos, G.P. (1996) Molecular aspects of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrine Reviews (in press).
7. Chang, S.S., Grunder, S., Hanukoglu, A., Rosler, A., Mathew, P.M., Hanukoglu, I., Schild, L., Lu, Y., Shimkets, R.A., Nelson-Williams, C., Rossier, B.C. & Lifton, R.P. (1996) Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nature Genetics, 12, 248-253.
8. Cheek, D.B. & Perry, J.W. (1958) A salt wasting syndrome in infancy. Archives of Disease in Childhood, 33, 252-256.
9. Cole, T.J., Blendy, J.A., Monaghan, A.P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzz, G., Hummler, E., Unsicker, K. & Schutz, G. (1995) Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Development, 9, 1608-1621.
10. Denault, D.L., Fejes-Toth, G. & Naray-Fejes-Toth, A. (1996) Aldosterone regulation of sodium channel γ-subunit mRNA in cortical collecting duct cells. American Journal of Physiology (in press).
11. Edwards, C.R.W., Stewart, P.M., Burt, D., Brett, L., McIntyre, M.A., Sutanto, W.S., de Kloet, R.R. & Monder, C. (1988) Localization of 11β hydroxysteroid dehydrogenase tissue specific protector of the mineralocorticoid receptor. Lancet, ii, 986-989.
12. Funder, J.W., Pearce, P., Myles, K. & Roy, L.P. (1990) Apparent mineralocorticoid excess: pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of 'mineralocorticoid' action. FASEB Journal, 4, 3234-3238.
13. Funder, J.W., Pearce, P.T., Smith, R. & Smith, A.I. (1988) Mineralocorticoid action: target-tissue specificity is enzyme, not receptor, mediated. Science, 242, 583-585.
14. Gomez-Sanchez, E.P., Fort, C.M. & Gomez-Sanchez, C.E. (1990a) Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. American Journal of Physiology, 258, E482-E484.
15. Gomez-Sanchez, E.P., Fort, C.M. & Thwaites, D.E. (1992) Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. American Journal of Physiology, 263, E96-E99.
16. Gomez-Sanchez, E.P., Venkataraman, M.T., Thwaites, D. & Fort, C. (1990b) ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. American Journal of Physiology, 258, E649-E653.
17. Hollenberg, S.M., Weinberger, C., Ong, E.S., Cerelli, G. & Evans, R.M. (1985) Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature, 318, 635-641.
18. Komesaroff, P.A., Verity, K. & Fuller, P.J. (1994) Pseudohypoaldosteronism: molecular chracterization of the mineralocorticoid receptor. Journal of Clinical Endocrinology, 79, 27-31.
19. Kralli, A. & Yamamoto, K.R. (1996) An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. Journal of Biological Chemistry (in press).
20. Krozowski, Z.S. & Funder, J.W. (1983) Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proceedings of the National Academy of Sciences U S A, 80, 6056-6060.
21. Lamberts, S.W.J., Huizenga, A.T.M., de Lange, P., de Jong, F.H. & Koper, J.W. (1996) Clinical and experimental aspects of glucocorticoid resistance. Steroids (in press).
22. Lifton, R.P., Dluhy, R.G., Powers, M., Rich, G.M., Cook, S., Ulick, S. & Lalouel, J-M. (1992) A chimaeric 11β-hydrolase aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertnesion. Nature, 335, 262-265.
23. Liu, W.H., Wang, J., Sauter, N.K. & Pearce, D. (1995) Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proceedings of the National Academy of Science U S A, 92, 12480-12484.
24. McEwen, B.S., Lambdin, L.T., Rainbow, T.C. & De Nicola, A.F. (1986) Aldosterone effects on salt appetite in adrenalectomized rats. Neuroendocrinology, 43, 38-43.
25. Mune, T., Rogerson, F.M., Nikkila, H., Agarwal, A.K. & White, P.C. (1995) Human hypertension caused by mutations in the kidney isozyme of 11-beta-hydroxysteroid dehydrogenase. Nature Genetic, 10, 394-399.
26. Myles, K. & Funder, J.W. (1994) Type I (mineralocorticoid) receptors in the guinea pig. American Journal of Physiology, 267, E268-E272.
27. Naray-Fejes-Toth, A. & Fejes-Toth, G. (1990) Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells. American Journal of Physiology, 259, F672-F678.
28. Nikkila, H.,Tannin, G.M., New, M.I., Taylor, N.F., Kalaitzoglou, G., Monder, C. & White, P.C. (1993) Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. Journal of Clinical Endocrinology and Metabolism, 77, 687-691.
29. Nordeen, S.K., Bona, B.J., Beck, C.A., Edwards, D.P., Borrow, K.C. & DeFranco, D.B. (1995) The two faces of a steroid antagonist: when an antagonist isn't. Steroids, 60, 97-104.
30. Orchinik, M., Murray, T.F. & Moore, F.L. (1991) A corticosteroid receptor in neuronal membranes. Science, 252, 1848-1851.
31. Pearce, D. & Yamamoto, K.R. (1993) Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science, 259, 1661-1665.
32. Roland, B.L., Li, K.X.Z. & Funder, J.W. (1995) Hybridization histochemical localization of 11β-hydroxysteroid dehydrogenase Type 2 in rat brain. Endocrinology, 136, 4697-4699.
33. Sato, A. & Funder, J.W. (1996) High glucose stimulates aldosterone-induced hypertrophy via Type I mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology (in press).
34. Sheppard, K.E. & Funder, J.W. (1996) Specific nuclear localization of 11 dehydrocorticosterone in rat colon: evidence for a novel corticosteroid receptor. Endocrinology, 137, 3274-3278.
35. Shimkets, R.A., Warnock, D.G., Bositis, C.M., Nelson-Williams, C., Hansson, J.H., Schambelan, M., Gill Jr, J.R., Ulick, S., Milora, R.V., Findling, J.W., Canessa, C.M., Rossier, B.C. & Lifton, R.P. (1994) Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell, 79, 407-414.
36. Stewart, P.M., Krozowski, Z.S., Gupta, A., Milford, D.V., Howie, A.J., Sheppard, M.C. & Whorwood, C.B. (1996) Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet, 347, 88-91.
37. Trapp, T., Rupprecht, R., Castren, M., Reul, J.M.H.M. & Holsboer, F. (1994) Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron, 13, 1457-1462.
38. Van Steensel, B., van Binnendijk, E.P., Hornsby, C.D., van der Voort, H.T.M., Krozowski, Z.S., de Kloet, E.R. and van Driel, R. (1996) Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete nuclear domains. Journal of Cell Science (in press).
39. Wehling, M. (1994) Rapid effects of aldosterone: a novel concept of non-genomic steroid action evolves. In Genomic and Non-Genomic Effects of Aldosterone (ed. M. Wehling), pp. 109-149. CRC Press, Florida.
40. Wilson, R.C., Harbison, M.D., Krozowski, Z.S., Funder, W., Shackleton, C.H.L., Hanauske-Abel, H.M., Wi, J-Q., Hertecant, J., Moran, A., Neiberger, R.E., Balfe, J. W., Fattah, A., Daneman, D., Licholai, T. & New, M.I. (1995b) Several homozygous mutations in the gene for 11β-hydroxysteroid dehydrogenase Type 2 in patients with apparent mineralocorticoid excess. Journal of Clinical Endocrinology and Metabolism, 80, 3145-3150.
41. Wilson, R.C., Krozowski, Z.S., Li, K., Obeyesekere, V., Razzaghy-Azar, M., Harbison, M.D., Wei, J.Q., Shackleton, C.H.L., Funder, J.W. & New, M.I. (1995a) A mutation in the HSD11B2 gene in a family with Apparent Mineralocortieoid Excess. Journal of Clinical Endocrinology and Metabolism, 80, 2263-2266.
42. Young, M., Head, G. & Funder, J.W. (1995) Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. American Journal of Physiology, 269, E657-662.
43. Zennaro, M.C., Borensztein, P., Jeunemaitre, X., Armanini, D. & Soubrier, F. (1994) No alteration in the primary structure of the mineralocortieoid receptor in family with pseudohypoaldosteronism. Journal of Clinical Endocrinology and Metabolism, 79, 32-38.